Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Basu

Showing results (221-230 of 234) with videos related to

Pageof 24
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 14, 2014
Programmed cell death 1 (PD-1) and its ligand (PD-L1) in common cancers and their correlation with molecular cancer typeZoran Gatalica, Carrie Snyder, Todd Maney, et al.
Breast Cancer Research : BCR|January 20, 2026
Characterization of ESR1 alterations in patients with breast and gynecologic cancersGargi D Basu, Paige E Innis, Angela K Deem, et al.
Journal of Translational Medicine|June 13, 2009
Synthetic lethal RNAi screening identifies sensitizing targets for gemcitabine therapy in pancreatic cancerDavid O Azorsa, Irma M Gonzales, Gargi D Basu, et al.
Annals of Human Biology|September 6, 2007
YAP insertion signature in South AsiaA Chandrasekar, S Y Saheb, P Gangopadyaya, et al.
Oncotarget|July 25, 2025
Comprehensive genomic profiling of over 10,000 advanced solid tumorsJean-Paul De La O, Jess R Hoag, Angela K Deem, et al.
Journal of Medical Economics|March 31, 2026
Costs and benefits of whole-exome, whole-transcriptome sequencing versus 50-gene panels for genomic profiling in solid tumorsJesse D Ortendahl, Gebra Cuyun Carter, Eliza M Zantema, et al.
Oncotarget|April 23, 2021
Analytic validation and clinical utilization of the comprehensive genomic profiling test, GEM ExTra<sup>®</sup>Tracey White, Szabolcs Szelinger, Janine LoBello, et al.
Oncogene|June 17, 2014
Cellular senescence checkpoint function determines differential Notch1-dependent oncogenic and tumor-suppressor activitiesS Kagawa, M Natsuizaka, K A Whelan, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|December 11, 2025
Cost-cutting at the expense of care and training: The predictable consequences of attempts at austerity by the Gauteng Department of HealthF Senkubuge, P Soma-Pillay, D Basu, et al.
JCO Precision Oncology|May 11, 2022
Comprehensive Genomic Profiling of High-Risk Pediatric Cancer Patients Has a Measurable Impact on Clinical CareRyan J Summers, Sharon M Castellino, Christopher C Porter, et al.
Pageof 24

Showing results (221-230 of 234) with videos related to

Sort By:
Pageof 24
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 14, 2014
Programmed cell death 1 (PD-1) and its ligand (PD-L1) in common cancers and their correlation with molecular cancer typeZoran Gatalica, Carrie Snyder, Todd Maney, et al.
Breast Cancer Research : BCR|January 20, 2026
Characterization of ESR1 alterations in patients with breast and gynecologic cancersGargi D Basu, Paige E Innis, Angela K Deem, et al.
Journal of Translational Medicine|June 13, 2009
Synthetic lethal RNAi screening identifies sensitizing targets for gemcitabine therapy in pancreatic cancerDavid O Azorsa, Irma M Gonzales, Gargi D Basu, et al.
Annals of Human Biology|September 6, 2007
YAP insertion signature in South AsiaA Chandrasekar, S Y Saheb, P Gangopadyaya, et al.
Oncotarget|July 25, 2025
Comprehensive genomic profiling of over 10,000 advanced solid tumorsJean-Paul De La O, Jess R Hoag, Angela K Deem, et al.
Journal of Medical Economics|March 31, 2026
Costs and benefits of whole-exome, whole-transcriptome sequencing versus 50-gene panels for genomic profiling in solid tumorsJesse D Ortendahl, Gebra Cuyun Carter, Eliza M Zantema, et al.
Oncotarget|April 23, 2021
Analytic validation and clinical utilization of the comprehensive genomic profiling test, GEM ExTra<sup>®</sup>Tracey White, Szabolcs Szelinger, Janine LoBello, et al.
Oncogene|June 17, 2014
Cellular senescence checkpoint function determines differential Notch1-dependent oncogenic and tumor-suppressor activitiesS Kagawa, M Natsuizaka, K A Whelan, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|December 11, 2025
Cost-cutting at the expense of care and training: The predictable consequences of attempts at austerity by the Gauteng Department of HealthF Senkubuge, P Soma-Pillay, D Basu, et al.
JCO Precision Oncology|May 11, 2022
Comprehensive Genomic Profiling of High-Risk Pediatric Cancer Patients Has a Measurable Impact on Clinical CareRyan J Summers, Sharon M Castellino, Christopher C Porter, et al.
Pageof 24